This publication contains the proceedings of a seminar held in Toulouse, France, on 10th, 11th and 12th June 1980, under the auspices of the Commission of the European Communities, Directorate General for Agriculture, Division for the Coordination of Agricultural Research, as part of a programme of research on beef production. The seminar was intended to bring together available experience on the utilisation of hereditary muscular hypertrophy for meat production in the member states of the European Communities. Although the phenomenon of double muscling has been exploited in various countries, particularly France, Italy and Belgium, different breeds are used and different methods of exploitation employed. An attempt was therefore made to bring together the collective experience of participants. Contributions ranged from those on the inheritance of muscular hypertrophy to alternative production systems and from fundamental studies of muscle growth to practical ways of selling the additional musrile found in animals with muscular hypertrophy. The collection of assembled papers and discussions thus represents one of the most extensive reviews of the subject that has been attempted.

At the end of September 1984 Dr. M. Velickovi and Prof. H. Prechtl with the help of the International Cerebral Palsy Society organized an international conference on "New develop ments in the assessment of early brain damage" in Bled, Yugo slavia. I was invited as a speaker at this conference and I went there, curious, but without too much knowledge about the central theme: cerebral palsy. During the conference and a satellite meeting I became impressed by the quality of various contributions and also by the great variety of problems related to the etiology, early diagnosis, management and psychosocial aspects of cerebral palsy. Today, in many areas of biology and medicine, progress seems to require concentration on a very narrow field. As a consequence many conferences are highly specialized and most (young) scientists rightly consider this as most useful for their own work. On the other hand the care of patients and counselling of parents and other close relatives require a multidisciplinary approach. Also, advances in the study of complicated un resolved medical biological pr'oblems are often made unex pectedly by using ideas, theories, approaches or methods from other disciplines."

Where do you begin to look for a recent, authoritative article on the diagnosis or management of a particular malignancy? The few general oncology textbooks are generally out of date. Single papers in specialized journals are informative but seldom comprehensive; these are more often preliminary reports on a very limited number of patients. Certain general journals frequently publish good indepth reviews of cancer topics, and published symposium lectures are often the best overviews available. Unfor tunately, these reviews and supplements appear sporadically, and the reader can never be sure when a topic of special interest will be covered. Cancer Treatment and Research is a series of authoritative volumes which aim to meet this need. It is an attempt to establish a critical mass of oncology literature covering virtually all oncology topics, revised frequently to keep the coverage up to date, easily available on a single library shelf or by a single personal subscription. We have approached the problem in the following fashion. First, by dividing the oncology literature into specific subdivisions such as lung can cer, genitourinary cancer, pediatric oncology, etc. Second, by asking emi nent authorities in each of these areas to edit a volume on the specific topic on an annual or biannual basis. Each topic and tumor type is covered in a volume appearing frequently and predictably, discussing current diagnosis, staging, markers, all forms of treatment modalities, basic biology, and more."

Textbook of Zoonoses Comprehensive resource covering the aetiology, epidemiology and transmission cycle, clinical symptoms, diagnosis, and prevention and control strategies of the important zoonoses. Zoonoses are the diseases which can spread from animals to humans. This book covers all important zoonoses that are prevalent in today's world. As a modern learning resource, it incorporates recent scientific developments and concepts to give readers a complete overview of each zoonoses. Written by three well-qualified authors in academia, sample topics covered within the book include: Bacterial, viral, parasitic, rickettsial, fungal, prion, and foodborne zoonoses Aetiology and epidemiology of each zoonotic disease Clinical symptoms and diagnosis in animals and humans Treatment options, plus prevention and control strategies CDC classification of zoonotic agents and the WHO's list of 'neglected zoonoses' Written for undergraduate and postgraduate students studying veterinary public health and epidemiology, Textbook of Zoonoses is also a helpful resource for other veterinary and medical professionals interested in public health and epidemiology.

Reproductive wastage is a major inefficiency in all livestock production with embryonic mortality accounting for a major portion of this loss. Accordingly the Commission of the European Communities encouraged the organisation of a seminar on embryonic mortality in farm animals which was held in Brussels on the 11th and 12th of December 1984. This book contains the text of the papers, discussions and final summary presented at that Seminar. As a background to the Seminar, the extent and timing of embryonic loss was described for farm animals. Particular consideration was then given to the various mechanisms and signals, both embryonic and uterine in origin, that are so far known to be involved in the establishment of pregnancy. Possible causes of embryonic death including physiological, endocrinological, genetic and immunological components were outlined and discussed. The final summary contains general conclusions from the Seminar and recommendations for future research work on this topic. J.M. Sreenan M.G. Diskin July 1985. ******************** THE EXTENT AND TIMING OF EMBRYONIC MORTALITY IN THE COW J. M. Sreenan & M. G. Diskin, The Agricultural Institute, Belclare, Tuam, Galway, Ireland ABSTRACT The extent and timing of embryonic mortality in heifers, normal cows and repeat breeder cows has been reviewed.

The 21st century will witness the unprecedented marketing of therapeutic drugs developed from cannabinoids and the endocannabinoid system. Cannabinoids is a timely volume, which represents a comprehensive review of the most important issues in cannabinoid research as well as those of most likely therapeutic relevance. For the first time, the multi-faceted aspects of cannabinoid chemistry, biology and medicine are presented in one volume.
Key topics of discussion:

-major families of phytocannabinoids;
-pharmacological activity of phytocannabinoids;
-interactions of phytocannabinoids with their proposed molecular target;
-components of the endocannabinoid system;
-molecular mechanisms of the endocannabinoid system;
-Physiological and pathological role of endocannabinoids;
-industrial applications of studies on the cannabinoids;
-therapeutic uses of agonists and antagonists of cannabinoids receptors. This book is a must for graduate and pre- and post-doctoral students in disciplines ranging from organic and natural product chemistry, pharmacology, biochemistry and medicine.

African swine fever (ASF) is caused by a virus that is classified as a member of the Iridovirinae family. The disease in the warthog, the natural host, in Africa was described in 1921 by R. E. Montgomery. The reservoir of the vi rus is inti cks. The i ntroduct i on of domestic pi gs into territory occupied by warthogs i nf ected wi th ASF in the 1960's has endangered the pig industry around the world. The domestic pig is highly sensitive to ASF and develops a devastating disease that kills the pig without giving the immune system a chance to defend the animal against the virus infection. The ability of ASF virus to infect and destroy cells of the reticuloendothelial system leaves a defenseless host that succumbs to an infection which may be described as an acquired immune deficiency di sease of domestic pi gs. Introduction of the virus into Iberia in the 1960's led to a series of ASF epidemics in Spain and Portugal . . and later in France, that caused heavy economic losses. Between 1976 and 1960, ASF virus made its appearance in Malta and Sardinia . . as well as in Brazil, The Dominican Republic . . Haiti, and later in Cuba. In 1985-6 . . ASF appeared in Belgium and The Netherlands.

Take a disease of complex pathology with inflammatory and neoplastic features, which affects lymphoid and neural tissues, belonging to a disease group which killed one chicken in five, and which defied efforts to understand and control it for lOre than 50 years, and one can begin to appreciate the interest Marek's disease has received. Canpound these characteristics with the finding of the causal herpesvirus, its recog nition as the neoplasm first discovered to be so caused, and its pre vention by vaccination, and the special place of Marek's disease in veterinary medicine and comparative oncology becomes clear. This book sets out to provide an authoritative and corrprehensive account of knowledge of Marek's disease and its control. I hope that it will be of value to veterinary research workers, teachers and students who need information about the disease, to veterinarians, poultrymen and vaccine manufacturers who have to diagnose and control it, and to oncologists in other fields interested in comparative aspects. other reviews of the disease exist, of course, but this is the first multi authored book devoted to the subject."

This book contains the contributions to a workshop on stress in farm animals held on April 17-18,1986 at the Pietersberg Con ference Centre Oosterbeek. The workshop was financed by the Commis sion of the European Communities from its budget for the coordina tion of Community Agricultural Research and the Agricultural Uni versity of Wageningen (The Netherlands). Its aim was to bring together experts from different disciplines all having in common that in one way or another they were involved in stress research. Such a multidisciplinary encounter should not only provide an interesting description of present day knowledge on stress, but also promote a more integrated view on stress phenomena as they occur in higher vertebrates. In the course of this workshop the following fields of research were related to stress: endocrinology, immunology, pathology, neurobiology, ethology and theoretical bio logy. Each of these relationships was introduce& by one speaker presenting a concise state of the art. The same relationship was elaborated by a second speaker implementing the available knowledge as far as possible to the farm animal situation. Therefore in this book each discipline is represented by a duo and introduced by some integrating remarks.

In some countries, especially on the European continent, there still exists a remarkable veal market. This type of meat production seems, irrespective of any economic forecasts, to remain unchallenged so long as consumers expect that restaurants should offer courses like "r6ti de veaux," "vitello a la casa" or "Kalbsschnitzel." Producers, at least since about the past 1-/2 decades, have been aware of the beneficial effect of anabolic agents in veal production. This is possible due to the lack of endogenous sexual hormones during the juvenile or prepuberal status of these animals. A discussion about the benefit / risk - evaluation in connection with the use of anabolic agents in general was promoted in recent years by the public. This concern occurred concomitantly with the detection of illegally treated veal calves and the occurrence of diethylstilbestrol (DES) residues in canned food containing veal. The aim of this paper is to summarize the present status of residue data in edible tissues and excreta in order to allow the evaluation of the risk (given in the paper of Hoffmann within this program) and to consider reasonable monitoring measures. We have to face the fact that without an efficient control system the illegal treatment of calves can not be excluded. Therefore, this paper will not only consider different compounds and formulations, but will also deal with practised routes of administration.

The farming of deer as an alternative to traditional livestock enterprises is now firmly established and is expanding within several countries of the European Economic Community. However, the successful farming of deer requires the adoption of appropriate management schemes to accommodate the biological requirements of these animals. Much experience has now been gained and it is essential that this information becomes readily available througout the Community. In addition, as the volume of deer farming has increased a number of health problems have become recognised which present features distinct from other domestic ruminants. Although knowledge is still incomplete it would appear that deer may react to certain pathogens in a very different way to other domestic ruminants, presenting new problems of diagnosis and control. The rapid detection of these conditions and development of appropriate control strategies will be essential for the establishment of an economically viable deer farming industry in the Community. Much of the information on the management of farmed deer and their diseases is anecdotal and fragmented and the purpose of this meeting was to accelerate the dissemination of this knowledge between scientists in the Community committed to the development of this area of agricultural industry. The meeting, financed by the Commission of the European Communities from its budget for the Coordination of Agricultural Research in the Community was held in Scotland, on the 10th to 11th December, 1987.

Proceedings of a workshop held at the International Center for Agricultural Research in the Dry Areas, Aleppo, Syria, November 30 to December 3, 1987

G. Petursson and Rikke Hoff-J0rgensen The concept of slow viral infections was first put forward in 1954 by Dr. Bjorn Sigurdsson, an Icelandic physician who had been studying some sheep diseases which were introduced into Iceland with the importation of a foreign breed of sheep in 1933. Sigurdsson's main criteria for defining slow infec tions were a very long initial period without clinical signs lasting months or even years following infection and a rather regular protracted, progres sive course, once clinical symptoms had appeared, usually ending in serious disease or death. Sigurdsson included in this list of slow infections maedi -visna, infectious adenomatosis of sheep, scrapie in sheep, Bittner's mam mary carcinoma and Gross' leukemia in mice. All of these diseases, except scrapie, are caused by retroviruses. The characteristics of slow infections as described above are of prac tical importance for epidemiology, diagnosis and control of these diseases. For many years the slow infections remained primarily a veterinary problem, mainly affecting sheep and goats in certain countries. In recent years, how ever, the human immunodeficiency virus (HIV) causing acquired immunodefici ency syndrome (AIDS), has suddenly appeared in many countries of the world and brought the slow infection concept forcefully to the attention of the medical profession. The disease problems and the economic effects of slow infections of sheep and goats are increasingly recognized in various coun tries. For the reasons stated above we feel that this book should be useful for veterinarians and physicians alike."

Radiophannaceuticals labeled with short-lived radionuclides are utilized to unravel biochemical processes, and to diagnosis and treat diseases of the living body are-developed through extensive evaluation in ~iological models. 'fhC first attempt to compile information was a volume entitled ANIMAL MODELS IN RADIOTRACER DESIGN that was edited by William C. Eckelman and myself in 1983. The volume had a focus on the animal models that investigators were using in order to design radiotracers that displayed in vivo selectivity as measured by biodistribution and pharmacokinetic studies. A concern in the early days of nuclear medicine was species differences. Often a series of labeled compounds were evaluated in a several different animal models in order to gain confidence that the selected radiotracer would behave appropriately in humans. During the past 12 years there have been remarkable advances in molecular genetics, molecular biology, synthetic radiopharmaceutical chemistry, molecular modeling and visualization, and emission tomography. Biological models can now be selected that are better defined in terms of molecular aspects of the disease process. The development of high resolution PET and SPET for clinical applications facilitates the development of new radiopharmaceuticals by the use of models to quantitatively evaluate drug effects, and progression of disease, and hence to arrive at better diagnosis and treatments for animals and humans. With these advances there is an effective use of biological models, and the refinement of alternatives for the development of new radiophannaceuticals.

The most rewarding aspect of writing a book is receiving encouraging comments from one's colleagues, since one always wonders whether fair coverage was made of the work of others or whether some omissions were made. I feel very fortunate that many colleagues took the time to read the first edition of this book and chose to use it as a textbook in their teaching. During the past few years they have given me valuable suggestions by pointing out areas that needed to be added to improve the book. Toxicology is one of the fastest moving scientific fields. In the areas of insecticide toxicology many new advances have been made since this treatise first appeared. Therefore, it would not be easy to write even a review paper that would not be outdated by the time it was published. In revising this volume I have made a conscious effort to adhere to the basic principles which have been developed over the years. While I have retained the basic framework of the original book, advances that fundamentally change certain concepts or add a new horizon have been chosen for updating those fields where applicable. The main emphasis has been placed on the addition of new sections and new compounds developed since 1975. Since the first edition appeared, several books covering technical details in each group have been published. They are excellent encyclopedic resources in their chosen areas, and are listed in each section as recommended reading material.

The third congress ofthe European Association for Veterinary Pharmacology and Toxicol ogy (EAVPT) was held in Ghent, Belgium, from 25 to 29 August 1985. Part I of the Proceedings of this congress contains the abstracts of all invited lectures, oral communi cations and poster communications, presented at the congress. The invited lectures are now published (this volume) in extenso as Part II of the Proceedings. The editors wish to thank all invited speakers for their active contribution to the success of the third congress of EAVPT. They are very grateful to Dr. P. De Backer for compiling all manuscripts, Dr. P. Lees for scientific amendments, Miss B. Vermeesch and Dr. R. Lefebvre for preparing the camera ready copy and MTP Press for literary advice and publishing. A. S. J. P. A. M. van Miert M. G. Bogaert M. Debackere xi Contributors AMEND J.F. Department of Anatomy and Physiology, Atlantic Veterinary College. University of Prince Edward Island. Charlotte town. P.E.I. CIA 4P3. Canada. ANIKA S.M. Department of Veterinary Physiology and Pharmacology. University of Nigeria, Nsukka. Nigeria. ARGENZIO R.A. Department of Anatomy, Physiological Sciences. and Radio logy, School of Veterinary Medicine. North Carolina State University. Raleigh, NC 27606. USA. ARONSON A.L. Clinical Pharmacology Unit. School of Veterinary Medicine. North Carolina State University, Raleigh. North Carolina 27606. USA. AUCOIN D.P. The Animal Medical Center. 510 E 62nd Street. New York. New York 10021. USA. xiii xiv COMPARATIVE VETERINARY PHARMACOLOGY, TOXICOLOGY AND THERAPY BAARS A.J."

Why are books written? Since I have read many works by my colleagues with admiration, this question has always intrigued me. Further, writing a book takes a good deal of time and effort, and I had imagined that I would never undertake such a demanding task. A few unexpected events and circumstances have changed my mind. The first was the pleasant experience of editing Environmental Toxicology of Pesticides with Drs. Mallory Boush and Tomomasa Misato. This fine symposium volume occasioned many interesting responses, including a suggestion to prepare a more complete treatise on the grounds that such "proceedings" volumes, by their very nature, do not satisfactorily offer a complete and coherent description of the field, but cater chiefly to specialists. I myself prefer single-authored books for basic understanding of a scientific field. The second circumstance leading to the present volume was the avail ability of teaching notes from my course on the toxicology of insecticides. As the need to cultivate environmental awareness has increased, there has been a parallel increase in the enrolments of such courses both here and in other major institutions. Yet no comprehensive and up-to-date text has been available. The third factor which facilitated the effort was an especially pleasant sabbatical in Hawaii, where the availability of the excellent Hamilton Library at the University of Hawaii considerably eased my task."

9. REFERENCES 90 CHAPTER 9: OPPORTUNITIES FOR REPLACEMENT, REDUCTION AND REFINEMENT: HUMAN VIRAL VACCINES 93 1. INTRODUCTION 93 2. TESTS FOR EXTRANEOUS MICROORGANISMS 94 3. MUMPS VACCINE . . . 94 4. HEPATITIS B VACCINE 95 4. 1. Test for freedom from live hepatitis virus 95 4. 2. Potency test 95 5. INFLUENZA VACCINE 96 5. 1. Potency test 96 5. 2. Abnormal-toxicity test 96 6. MEASLES VACCINE. . . . . 96 6. 1. Tests for extraneous agents 97 6. 1. 1. Test for Mycobacterium tuberculosis 97 6. 1. 2. Test for extraneous viruses 97 6. 2. Abnormal-toxicity test 98 7. POLIOMYELITIS VACCINE. . . 99 7. A. Inactivated poliomyelitis vaccine 99 7. A. l. Production. . . . . . 99 7. A. 2. Test for residual live virus 99 7. A. 3. Tests for extraneous agents 100 7. A. 3. l. Test for Mycobacterium tuberculosis . . . . . 100 7. A. 3. 2. Test for extraneous viruses 100 7. A. 4. Tumourigenicity test. . . . . 100 XII 7 . A. 5. Potency test . . . . . . . 101 7. A. 6. Test for abnormal toxicity 102 7. B. Live, oral poliomyelitis vaccine 103 7. B. l. Test for extraneous agents 103 7. B. 2. Test for neurovirulence 105 7. B. 3. Test for abnormal toxicity 106 8. RABIES VACCINE 106 8. 1. Production 106 8. 2. Test for residual live virus 107 8. 3. Tests for extraneous microorganisms 107 8. 3. 1. Test for Mycobacterium tuberculosis 107 8. 3. 2. Tests for extraneous viruses 108 8. 3. 2. 1. In dogs 108 8. 3. 2. 2.

This volume, the last in this series on cancer growth and Moreover, the current status of plant-derived vinca alka progression, is a companion volume to Volume IX and loids and non-alkaloid natural products is summarized. further explores established and novel approaches for the Advances in hyperthermia and additional approaches for therapy of patients with malignant neoplasms. The stra the therapy of malignancies are also presented. tegies reflected in these volumes are direct extrapolations The volume continues with chapters on bone marrow from the basic science of cancer biology, growth and pro transplantation as well as hematologic and nutritional sup gression described in earlier volumes of this series. Some port for the cancer patient. Blood pressure in the cancer approaches are directed towards the eradication or modifi patient, therapy for nausea and vomiting as well as pain are cation of the properties of heterogeneous malignant tumor discussed. The last chapter is devoted to the problems of the cells at various stages of tumor progression, while other terminally ill, including evaluations of the burden relatives approaches are directed towards modification of the host and friends of the cancer patient have to bear. antitumor defense systems, e. g., enhancement of host anti It is clear that important advances in the basic science of tumor immune reactivity."

The best protection against environmental mutagens is to identify them before they ever come into general use. But it is always possible that some substance will escape detection and affect a large number of persons without this being realized until later generations. This article considers ways in which such a genetic emergency might be promptly detected. A mutation-detecting system should be relevant in that it tests for effects that are as closely related as possible to those that are feared. It should be sensitive enough to detect a moderate increase in mutation rate, able to discover the increase promptly before more damage is done, responsive to various kinds of mutational events, and designed in such a way as to maxi- mize the probability that the Gause of an increase can be found. Methods based on germinal mutation necessarily involve enormous numbers of persons and tests. On the other hand, with somatic mutations the individual cell becomes the unit of measurement rather than the in- dividual person. For this reason, I think that somatic tests are preferable to germinal tests, despite the fact that it is germinal mutations which are feared.

Contrary to common belief, infectious diseases are not as well under control as we would like. We are now at a crossroads regarding the impact of the environment on infectious diseases. Renewed interest in biological weapons and the emergence of new pathogens, coupled with a better understanding of the impact of infectious agents on other conventional diseases, has led us to realise that we can no longer remain complacent about the impact of infectious agents on human, animal and crop health. The present book first discusses current and emerging military and civilian policies on the environment. In addition, the impact of environmental biology on the future of space exploration is discussed, especially in reference to the Mars mission. There follows a discussion of the state of bacteria in the environment, with a presentation of current and emerging techniques of microbial investigation. Finally, two case studies are presented on the impact of these techniques on both political and environmental problems.

Small Animal Dermatology: What's Your Diagnosis? provides practical information in an easy-to-reference, well-illustrated format, so that students and practicing veterinarians can develop their clinical dermatology skills and test their knowledge. It offers current diagnostic and therapeutic information on small animal skin diseases through real-world clinical cases. Organized by presenting complaint, each clinical problem is covered through case material and questions revolving around differential diagnoses, diagnostic tools, and treatment planning. Small Animal Dermatology: What's Your Diagnosis? features actual clinical cases that demonstrate common clinical presentations. It covers both common and uncommon dermatologic problems, such as alopecia, changes in skin pigmentation, causes of itch, and more. Designed to enhance clinical problem solving skills, the book can be approached as a series of mini challenges, making it an excellent primer for new clinicians as well as a resource for seasoned veterinarians. Provides information on diagnosing and treating small animal skin disease in a clinically relevant, case-based format Offers questions with detailed answers to enhance knowledge of differential diagnoses, diagnostic tools, and treatment options Takes a problem-based approach to the subject Helps practitioners and students to develop diagnostic and therapeutic skills and gain confidence Discusses dermatologic diseases ranging from common to rare Small Animal Dermatology: What's Your Diagnosis? is a helpful resource for veterinary practitioners and students to develop their skills in diagnosing and treating skin disease in dogs and cats.